tiprankstipranks
Trending News
More News >
AuMake Ltd. (AU:AUK)
:AUK
Australian Market

AuMake Ltd. (AUK) AI Stock Analysis

Compare
5 Followers

Top Page

AU

AuMake Ltd.

(Sydney:AUK)

Rating:49Neutral
Price Target:
AuMake Ltd. is facing significant financial challenges, including declining revenues, operational inefficiencies, and liquidity constraints. The technical analysis is neutral due to a lack of data, and the valuation metrics suggest potential risk given the negative P/E ratio and absence of dividend yield. These factors combined result in a relatively low overall stock score, suggesting caution for potential investors.

AuMake Ltd. (AUK) vs. iShares MSCI Australia ETF (EWA)

AuMake Ltd. Business Overview & Revenue Model

Company DescriptionAuMake Ltd. (AUK) is a retail company based in Australia that focuses on providing a wide range of consumer products primarily targeting Asian consumers, including tourists and international students. The company's core offerings include health supplements, beauty products, dairy products, and other Australian-made goods, catering to the increasing demand for high-quality products from Australia among Asian customers.
How the Company Makes MoneyAuMake Ltd. generates revenue primarily through the sale of consumer products via its retail stores and online platforms. The company operates a network of physical stores strategically located in key tourist destinations and urban centers frequented by international students and Asian tourists. Additionally, AuMake leverages e-commerce channels to reach a broader audience beyond physical store locations. Partnerships with popular Australian brands and suppliers enable AuMake to offer exclusive products and maintain competitive pricing, which are significant factors contributing to its earnings.

AuMake Ltd. Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
25.87M2.67M6.01M12.44M60.06M
Gross Profit
-1.00M60.17K551.40K1.78M25.35M
EBIT
-2.43M-2.18M-2.98M2.15M-5.76M
EBITDA
-2.04M-2.06M-3.16M-8.34M-2.14M
Net Income Common Stockholders
-6.28M-3.03M-6.18M-20.12M-5.15M
Balance SheetCash, Cash Equivalents and Short-Term Investments
2.03M1.55M3.04M4.26M8.23M
Total Assets
4.37M6.37M10.08M17.34M45.40M
Total Debt
2.19M0.00520.24K3.06M15.56M
Net Debt
206.65K-1.39M-2.52M-1.21M7.33M
Total Liabilities
3.80M1.26M5.98M11.98M29.37M
Stockholders Equity
524.74K5.11M4.13M5.39M16.03M
Cash FlowFree Cash Flow
-2.84M-3.46M-5.35M-10.48M-2.92M
Operating Cash Flow
-2.66M-3.46M-4.64M-7.99M3.01M
Investing Cash Flow
-318.20K-192.52K-159.08K-2.59M-5.87M
Financing Cash Flow
3.58M2.00M4.72M6.59M1.07M

AuMake Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUEZZ
78
Outperform
AU$70.76M7.3045.86%2.67%71.65%152.89%
62
Neutral
$6.84B11.412.80%3.87%2.70%-24.58%
AUAUK
49
Neutral
AU$9.07M-144.49%29.29%-45.83%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:AUK
AuMake Ltd.
0.01
0.00
0.00%
AU:EZZ
EZZ Life Science Holdings Ltd.
1.64
0.55
50.46%

AuMake Ltd. Corporate Events

AuMake Limited Announces Expiry of Quoted Options
May 2, 2025

AuMake Limited has announced the expiration of its quoted options, exercisable at $0.045 each, effective 31 May 2025. The company highlights that these options are significantly out of the money, with the highest market price of its shares in the past six months being $0.007, and the lowest at $0.003. As a result, the company will not dispatch personalized notices to option holders. If all options were exercised, 75,500,000 fully paid ordinary shares would be issued. However, without payment by the expiry date, the options will expire unexercised, and all rights will cease.

AuMake Director Increases Shareholding Through Option Conversion
May 1, 2025

AuMake Limited announced a change in the director’s interest, with Jiahua (Joshua) Zhou converting 4,666,667 zero exercise price options into fully paid ordinary shares. This change increases Zhou’s holdings to 117,560,672 ordinary shares, reflecting a strategic move in the company’s stock management.

AuMake Ltd. Issues Shares with Compliance Assurance
May 1, 2025

AuMake Ltd. has announced the issuance of fully paid ordinary shares without disclosure under Part 6D.2 of the Corporations Act, as per the notice under section 708A(5)(e). The company has complied with the necessary provisions of the Corporations Act, ensuring transparency and adherence to legal requirements, which is crucial for maintaining investor confidence and operational integrity.

AuMake Limited Announces Quotation of New Securities on ASX
May 1, 2025

AuMake Limited has announced the quotation of 12,666,667 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from April 30, 2025. This move is part of the company’s strategic financial operations, potentially impacting its market presence and offering new opportunities for investors.

AuMake Limited Reports Strong Q3 FY25 Performance and Strategic Partnerships
Apr 28, 2025

AuMake Limited reported significant growth in cash receipts for Q3 FY25, with a 160% increase compared to the previous year and an 11% rise from the previous quarter. The company has executed new partnership agreements, including deals with Sichuan Airlines E-Commerce and Kabrita, which are expected to drive future sales growth. Operational improvements have led to a 75% reduction in net cash used in operations. The company is focused on cash flow management and aims to achieve break-even while maintaining sales growth.

AuMake Limited’s Subsidiary Pursues Legal Action for Deposit Recovery
Apr 28, 2025

AuMake Limited’s subsidiary, 168 Express Pty Ltd, has filed a Statement of Claim in the District Court of NSW against iRich Foods Pty Ltd and its director, Mr. Weifeng Chen, for the recovery of a $678k deposit. The company is confident in successfully recovering the deposit and legal costs from the defendants, which could positively impact its financial standing and reassure stakeholders of its proactive legal measures.

Aumake Limited Cuts Executive Salaries to Boost Profitability
Apr 7, 2025

Aumake Limited has announced a significant reduction in board fees and executive director salaries, resulting in annual savings of over $400,000. This decision is part of a broader initiative to review and reduce the company’s fixed cost base, aiming to achieve cash flow positivity and profitability. The company is focusing on maximizing cash utilization to support growth in key sales channels and launching new products, especially as it forms new higher-margin brand partnerships. Aumake sees strong growth potential in China and is well-positioned to deliver long-term value to shareholders through strategic efficiency and financial discipline.

Aumake Secures Exclusive Distribution Deal for Kabrita Goat Milk Products
Apr 2, 2025

Aumake Limited has secured an exclusive distribution agreement for Kabrita High-Calcium Adult Goat Milk Powder in Australia and New Zealand, effective until December 2027. This strategic partnership allows Aumake to expand its footprint in the functional food sector and capitalize on the growing demand for premium nutrition products in these regions. The agreement enhances Aumake’s portfolio and positions the company to potentially form similar partnerships with other global health and nutrition brands in the future.

Aumake Expands Chinese Market Reach with Henan Wanbang Partnership
Mar 20, 2025

Aumake Limited has entered a strategic distribution agreement with Henan Wanbang Huinong Supply Chain Management Co., a major Chinese private distributor. This partnership significantly enhances Aumake’s market reach and revenue stability in China by providing a structured and scalable entry into the retail and wholesale markets. The agreement allows Aumake to maintain pricing control and adapt to market trends through regular sales data and insights, ensuring sustained revenue growth and competitive differentiation in China’s premium imported goods sector.

AuMake Limited Announces Options Quotation Update
Mar 12, 2025

AuMake Limited has announced an update regarding the proposed quotation of its options, as detailed in a prospectus dated March 10, 2025. The update includes a distribution schedule and a report on the top 20 holders of these options, which are set to expire on October 23, 2026. This move is likely to impact the company’s market positioning by potentially increasing liquidity and attracting more investors, as evidenced by significant holdings from entities like Zoomcoo Holdings Pty Ltd and Sovereign International Pty Ltd.

AuMake Limited Announces New Quoted Options Issuance
Mar 12, 2025

AuMake Limited has announced a new issuance of quoted options, set to expire on October 23, 2026, with a total of 1,036,285,358 securities to be quoted. This development could potentially impact AuMake’s market positioning by providing additional liquidity and investment opportunities, which may influence stakeholder engagement and the company’s future financial strategies.

Zoomcoo Holding Acquires Significant Stake in AuMake Limited
Mar 12, 2025

Zoomcoo Holding Pty Ltd has become a substantial holder in AuMake Limited, acquiring a 9.071% voting power through the direct ownership of 273,114,000 fully paid ordinary shares. This acquisition, completed on October 23, 2024, signifies a significant stake in AuMake Limited, potentially impacting the company’s strategic direction and shareholder dynamics.

AuMake Limited Announces Options Prospectus to Enhance Trading Flexibility
Mar 10, 2025

AuMake Limited has announced an options prospectus for the offer of up to 10,000 listed options at no consideration to remove trading restrictions on the sale of all listed options issued or quoted on the ASX by the company before the closing date. This move is aimed at enhancing liquidity and flexibility in trading the company’s options, with the offer closing on March 11, 2025. The options are considered speculative, and the offer is not underwritten, indicating a strategic approach to manage the company’s market presence and investor engagement.

Aumake Limited Appoints Dr. Anthony Noble as Non-Executive Chairman to Drive Strategic Growth
Feb 28, 2025

Aumake Limited has appointed Dr. Anthony Noble as the Non-Executive Chairman to spearhead its strategic growth initiatives. Dr. Noble’s extensive experience in eCommerce, international market expansion, and product development is expected to drive Aumake’s focus on premium products for the Chinese market, enhancing shareholder value and positioning the company as a key player in the health, wellness, and beauty segments.

AuMake Limited Reports Revenue Decline and Increased Losses for Half-Year 2024
Feb 26, 2025

AuMake Limited reported a 19% decrease in revenues for the half-year ended December 31, 2024, compared to the same period in 2023, with revenues totaling $13.57 million. The company’s loss from ordinary activities after tax increased by 42% to $1.93 million. No dividends were declared or paid during this period. Despite the financial downturn, the net tangible assets per ordinary security increased to 0.14 cents from 0.07 cents, and the company expanded its investment portfolio by establishing a joint venture in the wine and tourism industry.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.